An Italian research group has developed personalized glucocorticoid therapy for nephrotic syndrom diagnostic (a method based on genetic and epigenetic analysis for a personalized therapy). They are looking for companies active in the field of advanced diagnostics or involved in the development of companion diagnostic tests for complex diseases. A regional grant can support the co-development of the research results by paying the costs of one year research fellowship.
Submitted: May 29 2017
Updated: Jun 23 2017
Market: In vitro Testing, Trials, In-vitro diagnostics , Molecular diagnosis , Nephrology , Therapeutic services
Technology: Diagnostics, Diagnosis, In vitro Testing, Trials , Medical Research , Pharmaceutical Products / Drugs
NACE: Research and experimental development on biotechnology